149 related articles for article (PubMed ID: 2476366)
1. Red krypton and blue-green argon laser diabetic panretinal photocoagulation.
Blankenship GW; Gerke E; Batlle JF
Graefes Arch Clin Exp Ophthalmol; 1989; 227(4):364-8. PubMed ID: 2476366
[TBL] [Abstract][Full Text] [Related]
2. Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison.
Blankenship GW
Trans Am Ophthalmol Soc; 1986; 84():967-1003. PubMed ID: 2438841
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report number 1.
Ophthalmology; 1993 Nov; 100(11):1655-64. PubMed ID: 8233391
[TBL] [Abstract][Full Text] [Related]
4. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.
Blankenship GW
Ophthalmology; 1988 Feb; 95(2):170-7. PubMed ID: 2459641
[TBL] [Abstract][Full Text] [Related]
5. Treatment of proliferative diabetic retinopathy. Long-term results of argon laser photocoagulation.
Little HL
Ophthalmology; 1985 Feb; 92(2):279-83. PubMed ID: 2580259
[TBL] [Abstract][Full Text] [Related]
6. Electroretinographic findings in panretinal photocoagulation for diabetic retinopathy. A randomized study with blue-green argon and red krypton lasers.
Capoferri C; Bagini M; Chizzoli A; Pece A; Brancato R
Graefes Arch Clin Exp Ophthalmol; 1990; 228(3):232-6. PubMed ID: 2361594
[TBL] [Abstract][Full Text] [Related]
7. Treatment of recurrent juxtafoveal subretinal neovascular membranes with krypton red laser photocoagulation.
Olk RJ; Burgess DB
Ophthalmology; 1985 Aug; 92(8):1035-46. PubMed ID: 2413415
[TBL] [Abstract][Full Text] [Related]
8. Treatment of diffuse diabetic macular oedema: a comparison between argon and krypton lasers.
Casswell AG; Canning CR; Gregor ZJ
Eye (Lond); 1990; 4 ( Pt 5)():668-72. PubMed ID: 2282940
[TBL] [Abstract][Full Text] [Related]
9. The effect of short versus long exposure times of argon laser panretinal photocoagulation on proliferative diabetic retinopathy.
Wade EC; Blankenship GW
Graefes Arch Clin Exp Ophthalmol; 1990; 228(3):226-31. PubMed ID: 2193849
[TBL] [Abstract][Full Text] [Related]
10. Krypton laser for proliferative diabetic retinopathy: the Krypton Argon Regression of Neovascularization Study.
Singerman LJ; Ferris FL; Mowery RP; Brucker AJ; Murphy RP; Lerner BC; Mincey GJ
J Diabet Complications; 1988; 2(4):189-96. PubMed ID: 2466855
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of photocoagulation treatment in exudative age-related macular degeneration with the blue-green argon, green argon and red krypton laser wavelengths.
Atmaca LS; Ozmert E; Gündüz K
Ophthalmologica; 1993; 207(1):46-54. PubMed ID: 7506402
[TBL] [Abstract][Full Text] [Related]
12. Long-term visual outcome in proliferative diabetic retinopathy patients after panretinal photocoagulation.
Dogru M; Nakamura M; Inoue M; Yamamoto M
Jpn J Ophthalmol; 1999; 43(3):217-24. PubMed ID: 10413257
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of argon green and krypton red laser photocoagulation for patients with diabetic exudative maculopathy.
Khairallah M; Brahim R; Allagui M; Chachia N
Br J Ophthalmol; 1996 Apr; 80(4):319-22. PubMed ID: 8703882
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Macular Photocoagulation Study (MPS) Group.
Arch Ophthalmol; 1994 Sep; 112(9):1176-84. PubMed ID: 7522004
[TBL] [Abstract][Full Text] [Related]
15. [Effect of argon laser photocoagulation on diabetic retinopathy].
Wei ZY; Hu SX; Tang N; Wu J; Wang J
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1313-5. PubMed ID: 15567792
[TBL] [Abstract][Full Text] [Related]
16. Panretinal photocoagulation in diabetic retinopathy: argon versus dye laser coagulation.
Seiberth V; Schatanek S; Alexandridis E
Graefes Arch Clin Exp Ophthalmol; 1993 Jun; 231(6):318-22. PubMed ID: 8339946
[TBL] [Abstract][Full Text] [Related]
17. Argon versus krypton panretinal photocoagulation side effects on the anterior segment.
Menchini U; Scialdone A; Pietroni C; Carones F; Brancato R
Ophthalmologica; 1990; 201(2):66-70. PubMed ID: 2234817
[TBL] [Abstract][Full Text] [Related]
18. Argon green and krypton red laser treatment of diabetic macular edema.
Cruess AF; Williams JC; Willan AR
Can J Ophthalmol; 1988 Oct; 23(6):262-6. PubMed ID: 3203238
[TBL] [Abstract][Full Text] [Related]
19. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.
Blankenship GW
Trans Am Ophthalmol Soc; 1987; 85():176-94. PubMed ID: 2451871
[No Abstract] [Full Text] [Related]
20. [Effects of red krypton and monochromatic green argon lasers in the foveal region. A clinical and experimental study].
Soubrane G; Coscas G; Koenig F; Binaghi M
J Fr Ophtalmol; 1984; 7(2):107-13. PubMed ID: 6206121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
